Thus, we measured the expression status of PRMT5 by immunohistochemical staining and examined its correlation with the SUVmax obtained by PET/CT imaging, which reflects glucose uptake in pancreatic cancer patients. This evidence concerns the gene PRMT5 and pancreatic neoplasm.